Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: carranza2 who wrote (50149)	1/30/2002 7:41:41 PM
From: Eric L	Respond to of 54805

c2, << Have the G&Kers ever considered any drug companies as candidates? >> NO! ... and if you have the common courtesy and would take the !@#$%^& time to RTFM (just the first chapter or two even) as you have been politely requested to do on several occasions, you would understand why. If you would like to start a thread on the application of Gorilla Gaming to non-techs, have at it. << I'm looking at Pfizer >> Fine company. Fine stock. Not suitable for discussion here. This board discusses Gorilla & King portfolio candidates. regular participants are asked to read the manual. Best, - Eric -

To: carranza2 who wrote (50149)	1/31/2002 3:40:30 AM
From: Bruce Brown	Read Replies (1) \| Respond to of 54805

Have the G&Kers ever considered any drug companies as candidates? I'm looking at Pfizer, and I'm impressed. It has a long drug pipeline, enormous and increasing R&D expenditures, and is quite profitable. Difficult to apply the technology adoption life cycle and standards based criteria to the drug companies as presented to us in the book. There are other strategies best employed when reviewing the drug companies, patents, pipelines and competition which can be discussed on the message boards devoted to drug companies here (or at the Fool). BB